biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sinbobon Mar 28, 2013 2:41pm

125 Views

Post# 21182043

RE: RE: : Speculation...

As usual, Yak Yak, you don't answer the relevant, simple and obvious question pertaining to you directly and to your post... because that would force you to confront the truth. What do you suppose is the statistical significance of that?

When people try to evade and divert, it is hardly truthful... and fools no one. It is very blatant and disingeniune. ( logic 101).

No wonder you are so confused. Try to remember now, I am responding directly to your posts.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages